Loading...
ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
Interleukin enhancer-binding factor 3 (ILF3) may function as a transcriptional coactivator and has been reported to be involved in tumor proliferation and metastasis; however, its role and clinical value in gastric cancer (GC) remains unclear. To understand the value of ILF3 in GC, a total of 80 mat...
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6579973/ https://ncbi.nlm.nih.gov/pubmed/31115508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10229 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|